CLINICAL_TRIALS
trial_result
· 2014-01-30
Clinical Trial Update: Study of SB939 in Subjects With Myelofibrosis [Phase 2]
Summary
Phase 2 study of the investigational drug SB939 in patients with myelofibrosis has completed, with results posted in January 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloproliferative Disorders | Phase 2 | Status: COMPLETED | Results posted: 2014-01-30